Schor Chen
CIK 0001340875
President & CEODirector
Filings
17
Latest May 26, 2026
Issuers covered
2
Showing
17 of 17
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 50% | +0.9% | +1.8% | +7.7% | -7.7% |
| 90 days | 4 | 50% | +6.6% | 0.0% | +53.4% | -27.0% |
| 180 days | 4 | 50% | +3.3% | 0.0% | +83.2% | -70.1% |
| 365 days | 4 | 50% | +0.8% | 0.0% | +8.4% | -5.1% |
Issuers
Companies where Schor Chen has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACET | Adicet Bio, Inc. | 12 | Mar 27, 2026 |
| KPTI | Karyopharm Therapeutics Inc. | 5 | May 26, 2026 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|